Evidence map›Paper›PMID 37193121›Full record

ArticleJournal of hazardous materials advances2023

Exploring the correlations between

Ana R Silva, Daniela P Mesquita, M Salomé Duarte, Ana R Lado Ribeiro, M Fernando R Pereira, M Madalena Alves, Sílvia Monteiro, Ricardo Santos, Mónica V Cunha, Sandra Jorge and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of hazardous materials advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Ana R SilvaCEB, Centre of Biological Engineering, University of Minho, Braga 4710-057, Portugal.
Daniela P MesquitaCEB, Centre of Biological Engineering, University of Minho, Braga 4710-057, Portugal.
M Salomé DuarteCEB, Centre of Biological Engineering, University of Minho, Braga 4710-057, Portugal.
Ana R Lado RibeiroLSRE-LCM - Laboratory of Separation and Reaction Engineering - Laboratory of Catalysis and Materials, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, Porto 4200-465, Portugal.
M Fernando R PereiraLSRE-LCM - Laboratory of Separation and Reaction Engineering - Laboratory of Catalysis and Materials, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, Porto 4200-465, Portugal.
M Madalena AlvesCEB, Centre of Biological Engineering, University of Minho, Braga 4710-057, Portugal.
Sílvia MonteiroLaboratório de Análises de Águas, Técnico Lisboa, Universidade de Lisboa, Lisboa, Portugal.
Ricardo SantosLaboratório de Análises de Águas, Técnico Lisboa, Universidade de Lisboa, Lisboa, Portugal.
Mónica V CunhacE3c - Centre for Ecology, Evolution and Environmental Changes & CHANGE - Global Change and Sustainability Institute, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Sandra JorgeÁguas do Centro Litoral, S.A, Portugal.
Joana VieiraÁguas do Centro Litoral, S.A, Portugal.
João VilaçaSIMDOURO, S.A, Portugal.
Luísa C LopesSIMDOURO, S.A, Portugal.
Marta CarvalhoAdP VALOR- Serviços Ambientais, S.A, Portugal.
Carlos BritoAdP VALOR- Serviços Ambientais, S.A, Portugal.
António MartinsAdP VALOR- Serviços Ambientais, S.A, Portugal.
Luciana PereiraCEB, Centre of Biological Engineering, University of Minho, Braga 4710-057, Portugal.
United Nations University · PTUniversity of Lisbon · PTVale (Brazil) · BRUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 virus led to changes in the lifestyle and human behaviour, which resulted in different consumption patterns of some classes of pharmaceuticals including curative, symptom-relieving, and psychotropic drugs. The trends in the consumption of these compounds are related to their concentrations in wastewater systems, since incompletely metabolised drugs (or their metabolites back transformed into the parental form) may be detected and quantified by analytical methods. Pharmaceuticals are highly recalcitrant compounds and conventional activated sludge processes implemented in wastewater treatment plants (WWTP) are ineffective at degrading these substances. As a results, these compounds end up in waterways or accumulate in the sludge, being a serious concern given their potential effects on ecosystems and public health. Therefore, it is crucial to evaluate the presence of pharmaceuticals in water and sludge to assist in the search for more effective processes. In this work, eight pharmaceuticals from five therapeutic classes were analysed in wastewater and sludge samples collected in two WWTP located in the Northern Portugal, during the third COVID-19 epidemic wave in Portugal. The two WWTP demonstrated a similar pattern with respect to the concentration levels in that period. However, the drugs loads reaching each WWTP were dissimilar when normalising the concentrations to the inlet flow rate. Acetaminophen (ACET) was the compound detected at highest concentrations in aqueous samples of both WWTP (98. 516 μg

Indexed as

COVID-19PharmaceuticalsSludgeWastewater

Identifiers

PMID37193121
PMCPMC10171898
OpenAlexW4376871222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.